A functional deficiency of TERA/VCP/p97 contributes to impaired DNA repair in multiple polyglutamine diseases

Kyota Fujita1, Yoko Nakamura1, Tsutomu Oka1

  • 1Department of Neuropathology, Medical Research Institute, Tokyo Medical and Dental University, 1-5-45, Yushima, Bunkyo-ku, Tokyo 113-8510, Japan.

Insights

A common mechanism links neurodegenerative diseases: transitional endoplasmic reticulum ATPase (TERA)/valosin-containing protein (VCP)/p97

Area of Science:

  • Neurobiology
  • Molecular Biology
  • Genetics

Background:

  • Multiple neurodegenerative disorders may share a common underlying mechanism.
  • Polyglutamine diseases are a class of neurodegenerative disorders characterized by the expansion of polyglutamine tracts in specific proteins.

Purpose of the Study:

  • To investigate the potential common pathomechanism linking multiple polyglutamine diseases.
  • To elucidate the role of transitional endoplasmic reticulum ATPase (TERA)/valosin-containing protein (VCP)/p97 in the pathology of these diseases.

Main Methods:

  • Investigated the direct binding of TERA/VCP/p97 to polyglutamine disease proteins (huntingtin, ataxin-1, ataxin-7, androgen receptor).
  • Assessed the effect of normal and mutant polyglutamine proteins on TERA/VCP/p97 dynamism.
  • Examined the role of TERA/VCP/p97 in DNA double-stranded break repair in neuronal cells.
  • Utilized polyglutamine disease fly models to assess the therapeutic potential of TERA/VCP/p97.

Main Results:

  • TERA/VCP/p97 directly binds to polyglutamine proteins via the polyglutamine sequence.
  • Mutant polyglutamine proteins, but not normal ones, affect TERA/VCP/p97 dynamism.
  • TERA/VCP/p97's DNA double-stranded break repair function is critical for neuronal pathology in these diseases.
  • Mutant polyglutamine proteins impair TERA/VCP/p97 accumulation and DNA repair, leading to unrepaired double-stranded breaks.
  • TERA/VCP/p97 intervention improved double-stranded break repair and extended lifespan in fly models.

Conclusions:

  • A novel common pathomechanism in multiple polyglutamine diseases involves the DNA repair function of TERA/VCP/p97.
  • TERA/VCP/p97 is a potential therapeutic target for polyglutamine diseases.

Related Concept Videos

Nucleotide Excision Repair01:38

Nucleotide Excision Repair

DNA Distortion and Damage
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Nucleotide Excision Repair01:08

Nucleotide Excision Repair

Overview
Nucleotide Excision Repair01:08

Nucleotide Excision Repair

Overview
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Long-patch Base Excision Repair01:02

Long-patch Base Excision Repair

Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are:
Base-pairing and DNA Repair02:27

Base-pairing and DNA Repair

Erwin Chargaff’s rules on DNA equivalence paved the way for the discovery of base pairing in DNA. Chargaff’s rules state that in a double-stranded DNA molecule,